Association of rs738409 Polymorphism in Adiponutrin Gene with Liver Steatosis and Atherosclerosis Risk Factors in Greek Children and Adolescents
- PMID: 36079710
- PMCID: PMC9459993
- DOI: 10.3390/nu14173452
Association of rs738409 Polymorphism in Adiponutrin Gene with Liver Steatosis and Atherosclerosis Risk Factors in Greek Children and Adolescents
Abstract
Non-alcoholic fatty liver disease (NAFLD) shares several risk factors with atherosclerosis, as it is associated with components of the metabolic syndrome. However, genetic variations have also been linked to the risk of NAFLD, such as adiponutrin/patatin-like phospholipase domain-containing the protein 3 (PNPLA3) rs738409 polymorphism. The aim of the study was to determine the associations of thePNPLA3 rs738409 polymorphism with NAFLD and atherosclerosis risk factors in children and adolescents from northern Greece. A total of 91 children/adolescents who followed a Mediterranean eating pattern with no particular restrictions were studied. They were divided into three subgroups, according to their body mass index (BMI) and the presence or absence of liver disease. Diagnosis of NAFLD was based on a liver ultrasound, while the distribution of the PNPLA3 rs738409 polymorphism was investigated in all the participants. From the components of metabolic syndrome, only BMI, waist circumference, blood pressure, and the homeostasis model of insulin resistance (HOMA-IR) differed significantly between groups. The rs738409 polymorphism was significantly associated with BMI and NAFLD, while lipid values had no significant association with either NAFLD or gene polymorphism. This study shows that in Greekchildren, there is a significant association between the rs738409polymorphism in the PNPLA3 gene and hepatic steatosis, regardless of bodyweight.
Keywords: children; dyslipidemia; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; patatin-like phospholipase domain-containing 3 genotype.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.J Gene Med. 2020 Apr;22(4):e3160. doi: 10.1002/jgm.3160. Epub 2020 Feb 3. J Gene Med. 2020. PMID: 31945251
-
Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.Pediatr Obes. 2022 Feb;17(2):e12852. doi: 10.1111/ijpo.12852. Epub 2021 Sep 7. Pediatr Obes. 2022. PMID: 34490745
-
Associations of PNPLA3 rs738409 Polymorphism with Plasma Lipid Levels: A Systematic Review and Meta-Analysis.Horm Metab Res. 2022 Oct;54(10):686-695. doi: 10.1055/a-1929-1677. Epub 2022 Oct 7. Horm Metab Res. 2022. PMID: 36206762
-
Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.BMC Med Genet. 2020 Aug 18;21(1):163. doi: 10.1186/s12881-020-01098-8. BMC Med Genet. 2020. PMID: 32811452 Free PMC article.
-
Effect of the patatin-like phospholipase domain containing 3 gene (PNPLA3) I148M polymorphism on the risk and severity of nonalcoholic fatty liver disease and metabolic syndromes: A meta-analysis of paediatric and adolescent individuals.Pediatr Obes. 2020 Jun;15(6):e12615. doi: 10.1111/ijpo.12615. Epub 2020 Feb 5. Pediatr Obes. 2020. PMID: 32020770
Cited by
-
Significant roles of potential genes and their mutations in nonalcoholic fatty liver disease.Clin Exp Hepatol. 2023 Jun;9(2):95-105. doi: 10.5114/ceh.2023.128633. Epub 2023 Jun 21. Clin Exp Hepatol. 2023. PMID: 37502439 Free PMC article. Review.
-
Lipid Metabolism and Relevance to Chronic Disease.Nutrients. 2025 Jun 5;17(11):1936. doi: 10.3390/nu17111936. Nutrients. 2025. PMID: 40507205 Free PMC article.
References
-
- Kavey R.E., Allada V., Daniels S.R., Hayman L.L., McCrindle B.W., Newburger J.W., Parekh R.S., Steinberger J., American Heart Association Expert Panel on Population and Prevention Science. American Heart Association Council on Cardiovascular Disease in the Young et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. J. Cardiovasc. Nurs. 2007;22:218–253. - PubMed
-
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. National Heart, Lung, and Blood Institute Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics. 2011;128((Suppl. S5)):S213–S256. doi: 10.1542/peds.2009-2107C. - DOI - PMC - PubMed
-
- Xia M.F., Ling Y., Bian H., Lin H.D., Yan H.M., Chang X.X., Li X.-M., Ma H., Wang D., Zhang L.-S., et al. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders. Aliment. Pharmacol. Ther. 2016;43:631–642. doi: 10.1111/apt.13521. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical